Gyula Poór
Semmelweis University(HU)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Bone health and osteoporosis research, Monoclonal and Polyclonal Antibodies Research, Bone health and treatments
Most-Cited Works
- → EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update(2017)5,757 cited
- → EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update(2020)2,708 cited
- → EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update(2022)1,632 cited
- → Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis(1999)783 cited
- → 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative(2012)640 cited
- → Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial